Duke Clinical Research Institute, Durham (United States of America)
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial
